Regulatory, Pricing and Reimbursement Landscape Of Biosimilars In Australia

August 25, 2017

Poster presented at ISPOR USA, Boston, 20-24 May, 2017

Previous Flipbook
Mechanisms To Mitigate Healthcare Costs In The US: An International Comparative Analysis Of The Evolving Roles of HTA
Mechanisms To Mitigate Healthcare Costs In The US: An International Comparative Analysis Of The Evolving Roles of HTA

Next Flipbook
Undermining the Gold Standard? The Role of Non-Comparative Evidence in Health Technology Assessment
Undermining the Gold Standard? The Role of Non-Comparative Evidence in Health Technology Assessment